+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Acarbose"

Type 2 Diabetes Market Report 2025 - Product Thumbnail Image

Type 2 Diabetes Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Investigation Report on China's Acarbose Market, 2018-2022 - Product Thumbnail Image

Investigation Report on China's Acarbose Market, 2018-2022

  • Report
  • November 2018
  • 30 Pages
  • China
From
From
Anti-diabetic Drugs Market - Product Thumbnail Image

Anti-diabetic Drugs Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Acarbose is a drug used to treat endocrine and metabolic disorders. It is an alpha-glucosidase inhibitor, which works by slowing down the digestion of carbohydrates in the small intestine. This helps to reduce the amount of glucose absorbed into the bloodstream, which can help to control blood sugar levels in people with diabetes. Acarbose is also used to treat other conditions such as obesity and polycystic ovary syndrome. Acarbose is available in both generic and branded forms, and is sold in tablet and capsule form. It is usually taken three times a day, before meals. Common side effects include abdominal pain, flatulence, and diarrhea. The Acarbose market is highly competitive, with a number of companies offering products. Some of the major players in the market include Novo Nordisk, Sanofi, Merck, and Pfizer. Show Less Read more